TLPH Q3 2021 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q3 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2M+36.1% YoY

Gross Profit

$1M63.5% margin

Operating Income

-$9M-463.6% margin

Net Income

-$8M-449.8% margin

EPS (Diluted)

$-1.40

QoQ Revenue Growth

+320.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$72M

Total Liabilities

$115M

Stockholders' Equity

-$43M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+36.1%
Gross Profit	$1M	-$483,000	+344.6%
Operating Income	-$9M	-$9M	+4.5%
Net Income	-$8M	-$9M	+6.2%